학술논문

ITK Inhibitor Induces Dose-Dependent Th1 Skewing in Normal T Cells and Is Active in Refractory T Cell Lymphomas
Document Type
Abstract
Source
In Blood 15 November 2022 140 Supplement 1:8857-8859
Subject
Language
ISSN
0006-4971